SCHEMBL6002885

SCHEMBL6002885

[CH2]OCCc1nnnn1-c1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
ALDH1A1 P00352 3/20 0.51
LMNA P02545 3/20 0.47
NPSR1 Q6W5P4 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
MAPT P10636 1/20 0.45
HSD17B10 Q99714 1/20 0.44
GAA P10253 1/20 0.43
IDO1 P14902 1/20 0.43
PKM P14618 1/20 0.40
HTT P42858 1/20 0.40
NLRP3 Q96P20 1/20 0.40
HSD11B1 P28845 1/20 0.39
PTGS2 P35354 2/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2090294 0.84 ALDH1A1 (0.65) CYP1A2CYP2C19ALDH1A1LMNANPSR1
SCHEMBL5543435 0.81 ALDH1A1 (0.48) CYP1A2CYP2C19ALDH1A1LMNANPSR1
SCHEMBL5543439 0.81 ALDH1A1 (0.48) CYP1A2CYP2C19ALDH1A1LMNANPSR1
SCHEMBL25218290 0.79 CYP1A2 (0.60) CYP1A2CYP2C19ALDH1A1LMNANPSR1
SCHEMBL5546774 0.79 CYP1A2 (0.56) CYP1A2CYP2C19ALDH1A1LMNANPSR1
SCHEMBL25250647 0.77 ALDH1A1 (0.72) CYP1A2CYP2C19ALDH1A1LMNANPSR1
SCHEMBL14438051 0.77 ALDH1A1 (0.52) CYP1A2CYP2C19ALDH1A1LMNANPSR1
SCHEMBL5541570 0.77 ALDH1A1 (0.49) CYP1A2CYP2C19ALDH1A1LMNANPSR1
SCHEMBL14438050 0.76 ALDH1A1 (0.57) CYP1A2CYP2C19ALDH1A1LMNANPSR1
SCHEMBL2090296 0.75 ALDH1A1 (0.61) CYP1A2CYP2C19ALDH1A1LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed